Navigation Links
Meridian Clinical Research is a Finalist for Two Vaccine Industry Excellence Awards, Expects Elevated Demand for Vaccine Trials in 2020

Meridian Clinical Research, a leading investigative research network, is a finalist to win the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site. Meridian is also the largest member of Platinum Research Network, which is a finalist for the Best Clinical Trial Network award. These nominations were the result of two voting rounds, and winners will be announced at the World Vaccine Congress in Washington, D.C. in early April.

The nomination comes as Meridian has experienced its largest ever year for vaccine and infectious disease study enrollment. “We’re the partner of choice for many high-volume and specialized vaccine trials,” said Nicole Osborn, CEO. “2020 will be a crucial year for novel vaccine development. We’ve expanded our network, reinforced our in-house quality programs, and scaled up our processes to prepare for significant demand.”

As of mid-February, the CDC reported that influenza activity is still widespread in 47 states. The coronavirus (COVID-19) outbreak is also drawing greater attention in the U.S.

Meridian conducted clinical trials for Zika virus and anthrax vaccines in the past year. In 2015, Meridian also ran a Phase I study for the Ebola vaccine when the outbreak affected the Democratic Republic of Congo. Osborn said the spread of Zika and Ebola spurred many to ask Meridian about clinical trials.

“Our current patients and people naive to research are asking about coronavirus and the vaccine development process,” said Osborn. “Whenever there’s an outbreak, it gives healthcare providers an opportunity to educate people about the importance of clinical research. We encourage people to call us or talk to their doctors to learn more about the process.”

People interested in current studies and the research process can contact a Meridian call center — (402) 934-7563 in the Midwest and (912) 623-2240 for the South and East Coast.

To learn more about Meridian’s vaccine experience, visit To view current study and career opportunities at its locations across the U.S., visit


Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new pharmaceutical drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is headquartered at a dedicated research center in Omaha, NE, and conducts Phase I-IV studies at investigative sites across North America. Meridian supports research across numerous therapeutic areas and specializes in high-volume vaccine trials. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology news :

1. Mitotech and Essex Bio-Technology Announce Enrollment in VISTA-2 – a pivotal Phase 3 Clinical Study of SkQ1 for Dry Eye Disease
2. Roswell Park Spinoff Company Advances Toward New Clinical Trial for Brain Cancer Immunotherapy SurVaxM
3. Personalized Stem Cells, Inc. Announces First Patients Treated in FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
4. StageBio and Alizée Pathology join forces to meet the growing demand for high-quality histopathology and medical device services in the preclinical services market
5. Former Vice President and Global Head of Quantitative Clinical Pharmacology at AstraZeneca Joins NDA Partners
6. Advanced Clinical Expands Global Reach with New Romania Offices
7. Advanced Clinical Appoints Dr. Pavel Tyan to Lead and Enhance Therapeutic Oncology Research
8. Personalized Stem Cells, Inc. Announces First Patients Enrolled in FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
9. VISTAAR Announces Addition of “ADVISORY Playbooks” to it’s Regulatory & Clinical Intelligence Platform
10. Best Practices for EEG Analyses in Nonclinical Seizure Liability Studies, Upcoming Webinar Hosted by Xtalks
11. Capturing the Value of Clinical Trial Intelligence, New Webinar Hosted by Xtalks
Post Your Comments:
(Date:5/15/2020)... ... May 15, 2020 , ... The National Institutes of Health (NIH) ... based in Frederick, Maryland and Tysons Corner, Virginia, to provide patent legal services under ... another in the field of chemistry. The firm is one of nine firms in ...
(Date:5/6/2020)... Md. and LEXINGTON, Mass. (PRWEB) , ... May 06, 2020 , ... ... Hemanext Inc. , a privately held medical technology company dedicated to improving the quality, ... announce a new partnership that will help SCDAA deliver on its mission and meet ...
(Date:5/1/2020)... ... May 01, 2020 , ... More than 600 people undergo ... High-Risk Cancer Program, which is led by two genetic counselors. , My Gene ... it is teaming up with UConn’s High Rick Program to ensure that UConn’s patients ...
Breaking Biology News(10 mins):
(Date:5/26/2020)... PARK, Calif. (PRWEB) , ... May 26, 2020 , ... ... , the most recognized brand of smart garage door openers, announce a new integration ... line of Wi-Fi enabled garage door openers powered by Aladdin Connect® can now be ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... working cell banks and hMSC bioprocess systems, today announced the launch of ... hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with hMSC-EV ...
(Date:5/14/2020)... ... May 12, 2020 , ... NanoString Technologies , ... thousands of industry leaders, clinicians, research scientists, medical professionals and academics from around ... MD, Director of the Center for Cellular Immunotherapies at the Perelman School of ...
(Date:5/5/2020)... , ... May 05, 2020 , ... ProductLife Group ... high-profile CEO. Xavier Duburcq joins the group after 13 years at Altran, where he ... Holding a PhD in Immunology and being a Pharmacist, Xavier was involved in his ...
Breaking Biology Technology: